203 related articles for article (PubMed ID: 11410074)
1. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
Grossman W; Schmidramsl H
Altern Med Rev; 2001 Jun; 6(3):303-10. PubMed ID: 11410074
[TBL] [Abstract][Full Text] [Related]
2. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
Grossmann M; Schmidramsl H
Int J Clin Pharmacol Ther; 2000 Sep; 38(9):430-5. PubMed ID: 11020030
[TBL] [Abstract][Full Text] [Related]
3. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study.
Oelkers-Ax R; Leins A; Parzer P; Hillecke T; Bolay HV; Fischer J; Bender S; Hermanns U; Resch F
Eur J Pain; 2008 Apr; 12(3):301-13. PubMed ID: 17659990
[TBL] [Abstract][Full Text] [Related]
4. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract.
Pothmann R; Danesch U
Headache; 2005 Mar; 45(3):196-203. PubMed ID: 15836592
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review.
Agosti R; Duke RK; Chrubasik JE; Chrubasik S
Phytomedicine; 2006 Nov; 13(9-10):743-6. PubMed ID: 16987643
[TBL] [Abstract][Full Text] [Related]
6. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine.
Lipton RB; Göbel H; Einhäupl KM; Wilks K; Mauskop A
Neurology; 2004 Dec; 63(12):2240-4. PubMed ID: 15623680
[TBL] [Abstract][Full Text] [Related]
7. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria.
Diener HC; Rahlfs VW; Danesch U
Eur Neurol; 2004; 51(2):89-97. PubMed ID: 14752215
[TBL] [Abstract][Full Text] [Related]
8. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
11. Petasites hybridus (Butterbur root) extract in the treatment of asthma--an open trial.
Danesch UC
Altern Med Rev; 2004 Mar; 9(1):54-62. PubMed ID: 15005644
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine.
Mastrosimone F; Iaccarino C; de Caterina G
J Med; 1992; 23(1):1-16. PubMed ID: 1573338
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
